Clexane Enoxaparin 2000 IU Anticoagulant Injection Syringes 0.2ml 2s

• Prescription low-molecular-weight heparin (LMWH) • Contains 20 mg enoxaparin sodium ≡ 2000 anti-Xa IU per 0.2 mL pre-filled syringe • Ready-to-use subcutaneous injection • Pack of 2 pre-filled syringes with safety needle guard • For prevention and treatment of venous thromboembolism (VTE) • Requires a doctor’s prescription and usually hospital/clinic administration

Clexane 2000 IU / 0.2 mL is the lowest prophylactic dose of enoxaparin, a low-molecular-weight heparin derived from porcine heparin. It is indicated for: Prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in moderate-risk surgical patients Prophylaxis in medical patients with restricted mobility (e.g., acute illness, heart failure) Extended prophylaxis after hip/knee replacement or abdominal cancer surgery Some obstetric indications (under specialist supervision) It has a predictable anticoagulant effect, does not require routine monitoring (anti-Xa or aPTT), and has a lower risk of heparin-induced thrombocytopenia than unfractionated heparin. Benefits • Once-daily prophylactic dosing • No need for routine blood monitoring • Rapid onset and reliable 3–5 hour peak effect • Can be administered at home (after training) • Lower bleeding risk than continuous unfractionated heparin infusions • Proven to reduce VTE risk by up to 60–70% in moderate-risk patients How to Use • Usual prophylactic dose: 2000 IU (0.2 mL) subcutaneously once daily • Administer in the abdominal subcutaneous tissue (alternate left/right side) • Inject at 90° angle; do not expel air bubble; do not rub site after injection • First dose usually given 2 hours pre-op (general surgery) or in the evening for medical patients • Duration: usually until patient is fully mobile (5–10 days); longer after orthopaedic/cancer surgery • Safety needle automatically covers needle after use • Do not mix with other injections or infusions